NCT05137249View on ClinicalTrials.gov

The Glycocalyx in COVID-19 Patients. A Pilot Study

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

March 1, 2021

Study Completion Date

May 1, 2021

Conditions
COVID-19Endothelial DysfunctionCoagulation Disorder
Trial Locations (1)

Unknown

Medical University of Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT05137249 - The Glycocalyx in COVID-19 Patients. A Pilot Study | Biotech Hunter | Biotech Hunter